Subjects with essential hypertension are more sensitive to the inhibition of 11 β-HSD by liquorice

Journal of Human Hypertension

Volumn 17, Issue 2, 2003, Pages 125-131

  Sigurjonsdottir, Helga Á ^a   Manhem, K ^a   Axelson, M ^b   Wallerstedt, S ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

11 hydroxysteroid dehydrogenase; Gender hypertension; Glycyrrhetinic acid; Liquorice

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; 11BETA HYDROXYSTEROID DEHYDROGENASE TYPE 2; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CREATININE; GLYCYRRHETINIC ACID; HYDROCORTISONE; SODIUM; THYROXINE; UNCLASSIFIED DRUG;

ADULT; ARTHRALGIA; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD SAMPLING; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIARRHEA; DIASTOLIC BLOOD PRESSURE; DRUG USE; DYSPNEA; EDEMA; ENZYME INHIBITION; ESSENTIAL HYPERTENSION; FATIGUE; FEMALE; FOOD INTAKE; GLYCYRRHIZA; HEADACHE; HEARTBURN; HORMONE METABOLISM; HUMAN; HYDROCORTISONE URINE LEVEL; MALE; MENSTRUAL IRREGULARITY; METABOLITE; METEORISM; PLASMA RENIN ACTIVITY; SENSITIVITY ANALYSIS; SERUM; SEX DIFFERENCE; SODIUM BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; VERTIGO; WEIGHT GAIN;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; ADULT; BLOOD PRESSURE; BODY MASS INDEX; FEMALE; GLYCYRRHIZA; HUMANS; HYDROXYSTEROID DEHYDROGENASES; HYPERSENSITIVITY; HYPERTENSION; MALE; REFERENCE VALUES; SEX FACTORS;

EID: 0037291801     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001504     Document Type: Article

References (41)

1. Van Uum SHM et al. The role of 11 beta-hydroxysteroid dehydrogenase in the pathogenesis of hypertension. Cardiovasc Res 1998; 38: 16-24.
2. Funder JW. Mineralocorticoids, glucocorticoids, receptors and response elements. Science 1993; 259(February 19): 1132-1133.
3. Farese Jr RV et al. Licorice induced hypermineralcorticoidism. N Engl J Med 1991; 325: 1223-1227.
4. Albiston AL, Obeyesekere VR, Smith RE, Krozowski ZS. Cloning and tissue distribution of the human 11 beta-hydroxysteroid dehydrogenase type 2 enzyme. Mol Cell Endocrinol 1994; 105: R11-R17.
5. Monder C, White PC. 11 Beta-hydroxysteroid dehydrogenase. Vitam Horm 1993; 47: 187-271.
6. Brown RW, Chapman KE, Edwards CRW, Seckl JR. Human placental 11 beta-hydroxysteroid dehydrogenase. Evidence for and partial purification of a distinct NASD-dependent isoform. Endocrinology 1993; 132: 2614-2621.
7. Mercer WR, Krozowski SS. Localization of an 11 beta hydroxysteroid dehydrogenase activity to the distal nephron. Evidence for the existence of two species of dehydrogenase in the rat kidney. Endocrinology 1992; 130: 540-543.
8. Stewart PM, Murry BA, Mason I. Human kidney 11 beta-hydroxysteroid dehydrogenase is a high affinity nicotinamide adenine dinucleotide-dependent enzyme and differs from the cloned type 1 isoform. J Clin Endocr Metab 1994; 79: 480-484.
9. Walker BR, Campbell JC, Williams BC, Edwards CRW. Tissue-specific distribution of the NAD+-dependent isoform of 11 beta-hydroxysteroid dehydrogenase. Endocrinology 1992; 131: 970-972.
10. Ferrari P, Krozowski Z. Role of the 11 beta-hydroxysteroid dehydrogenase type 2 in blood pressure regulation. Kidney Int 2000; 57: 1374-1381.
11. Milford DV, Shackleton CHL, Stewart PM. Mineralocorticoid hypertension and congenital deficiency of 11 beta-hydroxysteroid dehydrogenase in a family with the syndrome of 'apparent' mineralocorticoid excess. Clin Endocrinology 1994; 43: 241-246.
12. Ulick S et al. A syndrome of apparent mineralocortocoid excess associated with defects in the peripheral metabolism of cortisol. J Clin Endocr Metab 1979; 49: 757-764.
13. Walker BR, Edwards CRW. Licorice-induced hypertension and syndromes of apparent mineralocorticoid excess. Endocrinol Metab Clin North Am 1994; 23: 359-377.
14. Epstein MT, Espiner EA, Donald RA, Hughes H. Liquorice toxicity and the renin-angiotensin-aldosterone axis in man. BMJ 1977; (January 22): 209-210.
15. Megia A, Herran L, Martin-Almendra MA, Martinez I. Angiotensin I-converting enzyme levels and renin-aldosterone axis recovery after cessation of chronic licorice ingestion. Nephron 1993; 65: 329-330.
16. Funder JW, Pierce PT, Smith R, Campbell J. Vascular type I aldosterone binding sites are physiological mineralocortocoid receptors. Endocrinology (Batimore) 1989; 125: 2224-2226.
17. Hatakeyama H, Satoru I, Miyamori I. 11 Beta-hydroxysteroid dehydrogenase in cultured human vascular cells. Possible role in the development of hypertension. Hypertension 1999; 33: 1179-1184.
18. Takeda Y et al. Gene expression of 11 beta-hydroxysteroid dehydrogenase in the mesenteric arteries of genetically hypertensive rats. Hypertension 1994; 23: 577-580.
19. Slight SH et al. High affinity NAD+-dependent 11 beta-hydroxysteroid dehydrogenase in the human heart. J Mol Cell Cardiol 1996; 28: 781-787.
20. Walker BR, Connacher AA, Webb DJ, Edwards CRW. Glucocorticoids and blood pressure: A role for the cortisol/cortisone shuttle in the control of vascular tone in man. Clin Sci 1992; 83: 171-178.
21. Walker BR et al. Increased vasoconstrictor sensitivity to glucocorticoids in essential hypertension. Hypertension 1996; 27: 190-196.
22. Walker BR et al. Deficient inactivation of cortisol by 11 beta-hydroxysteroid dehydrogenase in essential hypertension. Clin Endocrinol (Oxf) 1993; 39: 221-227.
23. Soro A et al. Evidence of coexisting changes in 11 beta-hydroxysteroid dehydrogenase and 5 beta-reductase activity in subjects with untreated essential hypertension. Hypertension 1995; 25: 67-70.
24. Takeda Y et al. Endogenous renal 11 beta-hydroxysteroid dehydrogenase inhibitory factors in patients with low-renin essential hypertension. Hypertension 1996; 27: 197-201.
25. Walker BR et al. Endogenous inhibitors of 11-beta hydroxysteroid dehydrogenase in hypertension. J Clin Endocr Metab 1995; 80: 529-533.
26. Sigurjonsdottir HA, Franzson L, Manhem K, Ragnarsson J, Sigurdsson G, Wallerstedts. Liquorice-induced rise in blood pressure: A linear dose-response relationship. J Hum Hypertens 2001; 15: 549-552.
27. Shea S, Cook F, Kannel W, Golman L. Treatment of hypertension and its effect on cardiovascular risk factors: Data from the Framingham Heart Study. Circulation 1985; 71: 22-30.
28. Axelson M, Sahlberg BL, Sjövall J. Analysis of profiles of conjugated steroids in urine by ion-exchange separation and gas chromatography-mass spectrometry. J Chromatogr 1981; 224: 355-370.
29. Mantel N. Chi-square tests with one degree of freedom; Extensions of the Mantel-Haenszel procedure. J Am Statist Assoc 1963; 58: 690-700.
30. Bradley JW. Distribution-free Statistical Tests. Prentice-Hall: London, 1968.
31. Odén A, Wedel H. Arguments for Fisher's permutations test. Ann Statist 1975; 3: 518-520.
32. Kannel WB. Fifty years of Framingham Study contributions to understanding hypertension. J Hum Hypertens 2000; 14: 83-90.
33. Sigurjonsdottir HA, Ragnarsson J, Franzson L, Sigurdsson G. Is blood pressure commonly raised by moderate consumption of liquorice? J Hum Hypertens 1995; 9: 345-348.
34. Fuster D et al. Furosemide inhibits 11 beta-hydroxysteroid dehydrogenase type 2. Endocrinology 1998; 139: 3849-3854.
35. Escher G et al. Furosemide inhibits 11 beta-hydroxysteroid dehydrogenase in vitro and in vivo. Endocrinology 1995; 136: 1759-1765.
36. Valentino R et al. Alcohol inhibits 11-beta-hydroxysteroid dehydrogenase activity in rat kidney and liver. Horm Res 1995; 43: 176-180.
37. Blachley JD, Knochel JP. Tobacco chewer's hypokalemia: Licorice revisited. N Engl J Med 1980; 302: 784-785.
38. Westman EC. Does smokeless tobacco cause hypertension. South Med J 1995; 88: 716-720.
39. Riddle MC, McDaniel PA. Renal 11 beta-hydroxysteroid dehydrogenase activity is enhanced by ramipril and captopril. J Clin Endocr Metab 1994; 78: 830-834.
40. Homma M et al. Activation of 11 beta-hydroxysteroid dehydrogenase by dehydroepiandrosterone sulphate as an anti-hypertensive agent in spontaneously hypertensive rats. J Pharm Pharmacol 1998; 50: 1139-1145.
41. Baulieu E-E. Dehydroepiandrosterone (DHEA): A fountain of youth? J Clin Endocr Metab 1996; 81: 3147-3151.